Class I - Dangerous
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
💊
Prescription Drugs
💊 Drugs • 12,141 recalls
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Class I - Dangerous
Miscalibrated and/or Defective Delivery System: Genentech has received complaints for Nutropin AQ NuSpin 10 & 20 reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Thyro-Tab 0.125 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
traMADOL Hydrochloride Tablets, USP 50 mg, 1000-count tablets per bottle, Manufactured by: Sun Pharmaceuticals Industries, Dadra 396 191, India; Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; NDC 57664-377-18.
Caraco Pharmaceutical Laboratories
Class I - Dangerous
Adulterated Presence of Foreign Tablets: A customer complaint was received that a bottle of Tramadol HCl Tablets USP 50 mg contained some tablets of Metoprolol Tartrate Tablets USP, 50 mg.
Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Lloyd Inc. of Iowa
Class I - Dangerous
cGMP Deviations; does not meet in process specification requirements
Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.
Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54
Boehringer Ingelheim Roxane
Class I - Dangerous
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Class I - Dangerous
Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Class I - Dangerous
Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.
Class I - Dangerous
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.